Insitro

Decodes biology using machine learning to discover new medicines

BiotechnologyDrug Discovery https://www.insitro.com ↗ LinkedIn ↗

Company facts

Founded
2018
Employees
253
Headquarters
United States
Type
Private
Funding
Series C · $400M · 2021
Subsidiaries
CombinAble.AI

About

Insitro is a data-driven biotech company focused on transforming drug discovery through machine learning and high-throughput biology. By integrating human genetics, functional genomics, and advanced computational methods, the company aims to accelerate the development of new therapies at lower costs, addressing unmet medical needs more effectively. Insitro's unique approach leverages diverse expertise in life sciences, engineering, and data science, fostering a collaborative culture dedicated to improving patient health outcomes.